Neuroblastic tumors account for 9-10\% of pediatric tumors and neuroblastoma (NB) is the first cause of death in pre-school age children. NB is classified in four stages, depending on the extent of spreading. A fifth type of NB, so-called stage 4S (S for special), includes patients with metastatic tumors but with an overall survival that approximates 75\% at five years. In most of these cases, the tumor regresses spontaneously and regression is probably associated with delayed neuroblast cell differentiation.In order to identify new early markers to follow and predict this process for diagnostic and therapeutics intents, we mimicked the differentiation process treating NB cell line SJ-NK-P with all-trans-retinoic acid (ATRA) at different times; therefore the cell proteomic pattern by mass spectrometry and the phosphoproteomic pattern by a 2-DE approach coupled with anti-phosphoserine and anti-phosphotyrosine western blotting were studied.PROTEOMIC ANALYSIS IDENTIFIED ONLY TWO PROTEINS WHOSE EXPRESSION WAS SIGNIFICANTLY DIFFERENT IN TREATED CELLS VERSUS CONTROL CELLS: nucleoside diphosphate kinase A (NDKA) and reticulocalbin-1 (RCN1), which were both downregulated after 9 days of ATRA treatment. However, phosphoproteomic analysis identified 8 proteins that were differentially serine-phosphorylated and 3 that were differentially tyrosine-phosphorylated after ATRA treatment. All proteins were significantly regulated (at least 0.5-fold down-regulated). Our results suggest that differentially phosphorylated proteins could be considered as more promising markers of differentiation for NB than differentially expressed proteins.

Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic Acid-treated neuroblastoma cells.

MANDILI, GIORGIA;ZANINI, CRISTINA;PRATO, Mauro;KHADJAVI, AMINA;TURRINI, Francesco Michelangelo;GIRIBALDI, Giuliana
2011-01-01

Abstract

Neuroblastic tumors account for 9-10\% of pediatric tumors and neuroblastoma (NB) is the first cause of death in pre-school age children. NB is classified in four stages, depending on the extent of spreading. A fifth type of NB, so-called stage 4S (S for special), includes patients with metastatic tumors but with an overall survival that approximates 75\% at five years. In most of these cases, the tumor regresses spontaneously and regression is probably associated with delayed neuroblast cell differentiation.In order to identify new early markers to follow and predict this process for diagnostic and therapeutics intents, we mimicked the differentiation process treating NB cell line SJ-NK-P with all-trans-retinoic acid (ATRA) at different times; therefore the cell proteomic pattern by mass spectrometry and the phosphoproteomic pattern by a 2-DE approach coupled with anti-phosphoserine and anti-phosphotyrosine western blotting were studied.PROTEOMIC ANALYSIS IDENTIFIED ONLY TWO PROTEINS WHOSE EXPRESSION WAS SIGNIFICANTLY DIFFERENT IN TREATED CELLS VERSUS CONTROL CELLS: nucleoside diphosphate kinase A (NDKA) and reticulocalbin-1 (RCN1), which were both downregulated after 9 days of ATRA treatment. However, phosphoproteomic analysis identified 8 proteins that were differentially serine-phosphorylated and 3 that were differentially tyrosine-phosphorylated after ATRA treatment. All proteins were significantly regulated (at least 0.5-fold down-regulated). Our results suggest that differentially phosphorylated proteins could be considered as more promising markers of differentiation for NB than differentially expressed proteins.
2011
6(5)
e18254
00
http://dx.doi.org/10.1371/journal.pone.0018254
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088664/pdf/pone.0018254.pdf
Mandili G; Marini C; Carta F; Zanini C; Prato M; Khadjavi A; Turrini F; Giribaldi G
File in questo prodotto:
File Dimensione Formato  
Mandili et al. 2012.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 528.13 kB
Formato Adobe PDF
528.13 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Mandili et al. 2012.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 528.13 kB
Formato Adobe PDF
528.13 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/89154
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 19
social impact